Publications by authors named "Eva Corey"

110Publications

Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer.

Cancer Res 2021 Jan 22. Epub 2021 Jan 22.

Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University

View Article and Find Full Text PDF
January 2021

Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression.

PLoS One 2021 22;16(1):e0244985. Epub 2021 Jan 22.

Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, United States of America.

View Article and Find Full Text PDF
January 2021

Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature.

PLoS One 2021 20;16(1):e0245602. Epub 2021 Jan 20.

Department of Urology, University of Washington School of Medicine, Seattle, Washington, United States of America.

View Article and Find Full Text PDF
January 2021

Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer.

Cancers (Basel) 2020 Nov 27;12(12). Epub 2020 Nov 27.

Cancer Biology and Therapeutics Laboratory, UCD Conway Institute, University College Dublin, Belfield, D4, Dublin, Ireland.

View Article and Find Full Text PDF
November 2020

FOXA2 promotes prostate cancer growth in the bone.

Am J Transl Res 2020 15;12(9):5619-5629. Epub 2020 Sep 15.

Department of Biochemistry and Molecular Biology, LSU Health Shreveport, LA, USA.

View Article and Find Full Text PDF
September 2020

Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress.

Cell Rep 2020 05;31(8):107669

Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98195, USA; Department of Urology, University of Washington, Seattle, WA 98195, USA. Electronic address:

View Article and Find Full Text PDF
May 2020

Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4.

Neoplasia 2020 06 11;22(6):253-262. Epub 2020 May 11.

Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. Electronic address:

View Article and Find Full Text PDF
June 2020

Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.

Hum Pathol 2020 Jul 7;101:70-79. Epub 2020 May 7.

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21287, USA.

View Article and Find Full Text PDF
July 2020

Radium-223 mechanism of action: implications for use in treatment combinations.

Nat Rev Urol 2019 12 11;16(12):745-756. Epub 2019 Nov 11.

Johns Hopkins University, School of Medicine, Baltimore, MD, USA.

View Article and Find Full Text PDF
December 2019